Archana Sharma

Archana Sharma


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2022 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
SKSanjeev Kumar
Sanjeev Kumar
JDJai Devi
Jai Devi
ADAmit Dubey
Amit Dubey
Deepak KumarDeepak Kumar
Deepak Kumar
DJDeepak Kumar Jindal
Deepak Kumar Jindal
ASArchana Sharma
Archana Sharma

30 May 2016 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
ASArchana Sharma
Archana Sharma
VKVipin Kumar
Vipin Kumar
RKRajeev Kharb
Rajeev Kharb
SKSunil Kumar
Sunil Kumar
PSPrabodh Chander Sharma
Prabodh Chander Sharma
DPDharam Pal Pathak
Dharam Pal Pathak
Background: The imidazole nucleus is inimitable and ubiquitous and it is very well known to play an important role in living organisms. Imidazole derivatives are under intensive scientific exploration due to their diverse and significant pharmacological activities. Methods: The present paper is an attempt to present chemistry, synthetic aspects including click chemistry procedures of imidazoles through systematic literature survey. Results: Biological activity profiles of the imidazole derivatives reported in recent scientific literature from 2000 to 2015 have been discussed in detail. It has been found that imidazole derivatives depict appreciable antiinfective activity potential. Conclusion: It is anticipated that the information compiled in this paper will be useful and motivating to prospective researchers working on this heterocylic scaffold.

28 June 2010 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
VKVipin Kumar
Vipin Kumar
ASArchana Sharma
Archana Sharma
PSPrabodh Chander Sharma
Prabodh Chander Sharma
Some new decanoic acid [2,5-disubstituted-4-oxo-thiazolidin-3-yl]amides (6a-j) have been synthesised by the condensation of decanoic acid hydrazide with various aromatic aldehydes to yield the Schiff's bases. Cyclocondensation of the Schiff's bases with thioglycollic acid afforded 4-thiazolidinone derivatives. The structures of the newly synthesised compounds were confirmed by analytical and spectral methods. The anti-inflammatory, analgesic and antioxidant activity of the title compounds were evaluated. Compound 6j exhibited 44.84 % inhibition of inflammation and was the most potent anti-inflammatory agent of the series whereas compound 6f demonstrated the most potent analgesic activity (69.82% inhibition of writhing) followed by compounds 6e and 6g. All the synthesised compounds exhibited a potent antioxidant activity.

1 October 2012 in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PSPrabodh Sharma
Prabodh Sharma
SYSonia Yadav
Sonia Yadav
RPRakesh Pahwa
Rakesh Pahwa
ASArchana Sharma
Archana Sharma
SJSandeep Jain
Sandeep Jain
Abstract: Naproxen is a propionic acid derivative related to the arylacetic acid group. This drug is one of the most popular non-steroidal anti-inflammatory agents. It is a non-selective cyclooxygenase inhibitor and is advocated for use in painful and inflammatory rheumatic and non-rheumatic conditions. In low risk patients, naproxen and ibuprofen may be the first choice agents because they are effective, well tolerated and inexpensive. Naproxen is rapidly and completely absorbed from the gastrointestinal tract with an in vivo bioavailability of 95% and elimination half-life is 12 to 17 h. It has a volume of distribution of 0.16 L/Kg and at therapeutic levels, it is more than 99% albumin-bound. Although introduced long back, several efforts have been done to develop its prodrugs and analytical procedures. The current article describes chemistry, pharmacology, pharmacokinetics, adverse effects, interactions and contraindications of naproxen. A special emphasis is laid on the review of recent literature of various prodrugs synthesized and analytical methods developed for determination of naproxen in pharmaceutical preparations.